DK3158057T3 - Stamcelleterapi ved endometriepatologier - Google Patents

Stamcelleterapi ved endometriepatologier Download PDF

Info

Publication number
DK3158057T3
DK3158057T3 DK15781411.2T DK15781411T DK3158057T3 DK 3158057 T3 DK3158057 T3 DK 3158057T3 DK 15781411 T DK15781411 T DK 15781411T DK 3158057 T3 DK3158057 T3 DK 3158057T3
Authority
DK
Denmark
Prior art keywords
endometry
pathologies
stem cell
cell therapy
therapy
Prior art date
Application number
DK15781411.2T
Other languages
Danish (da)
English (en)
Inventor
Javier Santamaria
Carlos Simón
Irene Cervello
Antonio Pellicer
Original Assignee
Igenomix S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igenomix S L filed Critical Igenomix S L
Application granted granted Critical
Publication of DK3158057T3 publication Critical patent/DK3158057T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
DK15781411.2T 2014-06-17 2015-06-05 Stamcelleterapi ved endometriepatologier DK3158057T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462013121P 2014-06-17 2014-06-17
PCT/IB2015/001715 WO2015193737A1 (en) 2014-06-17 2015-06-05 Stem cell therapy in endometrial pathologies

Publications (1)

Publication Number Publication Date
DK3158057T3 true DK3158057T3 (da) 2019-07-29

Family

ID=54329860

Family Applications (2)

Application Number Title Priority Date Filing Date
DK15781411.2T DK3158057T3 (da) 2014-06-17 2015-06-05 Stamcelleterapi ved endometriepatologier
DK19169309.2T DK3569697T3 (da) 2014-06-17 2015-06-05 Stamcelleterapi i endometriumpatologier

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK19169309.2T DK3569697T3 (da) 2014-06-17 2015-06-05 Stamcelleterapi i endometriumpatologier

Country Status (22)

Country Link
US (1) US11129851B2 (enExample)
EP (3) EP4012023B1 (enExample)
JP (2) JP6920062B2 (enExample)
CN (2) CN116747241A (enExample)
AU (1) AU2015275798B2 (enExample)
BR (1) BR112016029558A2 (enExample)
CA (1) CA2952559C (enExample)
CY (2) CY1122615T1 (enExample)
DK (2) DK3158057T3 (enExample)
ES (3) ES2983444T3 (enExample)
HR (3) HRP20191240T1 (enExample)
HU (3) HUE058328T2 (enExample)
LT (2) LT3569697T (enExample)
MX (1) MX377300B (enExample)
PL (3) PL3569697T3 (enExample)
PT (2) PT3569697T (enExample)
RS (3) RS65719B1 (enExample)
RU (1) RU2725006C2 (enExample)
SI (2) SI3569697T1 (enExample)
SM (3) SMT202400270T1 (enExample)
TR (1) TR201910410T4 (enExample)
WO (1) WO2015193737A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
EP3467124A1 (en) 2012-06-06 2019-04-10 Fundació Institut de Recerca Biomèdica IRB (Barcelona) Method for the diagnosis, prognosis and treatment of lung cancer metastasis
CA2888122A1 (en) 2012-10-12 2014-04-17 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf
US10119171B2 (en) 2012-10-12 2018-11-06 Inbiomotion S.L. Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
KR20150122786A (ko) 2013-03-15 2015-11-02 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) 암 전이의 진단, 예후 및 치료를 위한 방법
BR112016029558A2 (pt) 2014-06-17 2017-08-22 Igenomix S L terapia de células-tronco em patologias endometriais
AU2017281631B2 (en) * 2016-06-23 2023-06-15 Tithon Biotech, Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof
RU2699029C1 (ru) * 2018-12-10 2019-09-03 Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке
RU2741621C1 (ru) * 2020-09-25 2021-01-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации Способ лечения внутриматочных синехий

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240922A (en) 1989-05-05 1993-08-31 Northern Sydney Area Health Service Fertility enhancement
US6979533B2 (en) 1992-06-12 2005-12-27 The Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
CA2203718A1 (en) 1997-04-25 1998-10-25 University Of British Columbia Cadherin-11 as an indicator of viable pregnancy
IL127896A0 (en) 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
AU2001240096A1 (en) 2000-03-08 2001-09-17 Rebecca L. Dubowy Methods of diagnosing and monitoring endometrial glandular development
JP2004504275A (ja) 2000-05-24 2004-02-12 シエーリング　アクチエンゲゼルシャフト フィブリン−１の医薬用途
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
AUPR673001A0 (en) 2001-07-31 2001-08-23 Prince Henry's Institute Of Medical Research Pregnancy-related enzyme activity
DE10139874A1 (de) 2001-08-10 2003-04-30 Schering Ag Humane Mater-Proteine
GB0201284D0 (en) 2002-01-21 2002-03-06 Isis Innovation Screening methods for contraceptive and fertility agents
US20030186300A1 (en) 2002-03-20 2003-10-02 Ali Akoum Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions
EP1511863A4 (en) 2002-05-14 2006-12-27 Univ Leland Stanford Junior ENDOMETRIAL GENES FOR THE DETECTION OF ENDOMETRIAL DISORDERS
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
ATE338763T1 (de) 2002-08-02 2006-09-15 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10361928A1 (de) 2002-12-21 2004-07-01 Universität Leipzig Verfahren und Mittel zur Bestimmung von bestimmten Zuständen bzw. Veränderungen im Uterusepithel und im Epithel anderer Organe
EP1660228A1 (en) 2003-08-21 2006-05-31 PamGene B.V. Microarray support for bioprobe synthesis
EP1670902A4 (en) 2003-09-08 2008-05-07 Univ Texas METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG
JP2007504807A (ja) 2003-09-08 2007-03-08 ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成
DE602004028513D1 (de) 2003-12-23 2010-09-16 Mount Sinai Hospital Corp Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
JP2008501035A (ja) 2004-05-28 2008-01-17 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 妊孕性関連障害の治療におけるｉｌ−１７の使用
US20090111140A1 (en) * 2006-03-31 2009-04-30 Koninklijke Philips Electronics N.V. Systems and methods for cell measurement utilizing ultrashort t2*
JP2007278750A (ja) 2006-04-04 2007-10-25 Ono Pharmaceut Co Ltd プロスタグランジン類及びその類縁体の定量方法
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
GB0703683D0 (en) * 2007-02-26 2007-04-04 Ark Therapeutics Ltd The treatment of complications in pregnancy
US9259233B2 (en) * 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US8673850B2 (en) 2008-05-30 2014-03-18 Institut De Recherches Cliniques De Montreal PCSK9 inhibitors and methods of use thereof
WO2010010201A1 (es) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Perfil de expresion genetica como marcador de la receptividad endometrial
WO2013166281A1 (en) * 2012-05-02 2013-11-07 Cedars-Sinai Medical Center Bi-functional compositions for targeting cells to diseased tissues and methods of using same
EP2348318A1 (en) 2010-01-21 2011-07-27 Equipo Ivi Investigación, S.L. Diagnostic method for endometrial receptivity
PT2768976T (pt) 2011-10-21 2018-04-05 Inst Nat Sante Rech Med Métodos para avaliar a receptividade endométrica de uma paciente após hiperestimulação ovárica controlada
US9423402B2 (en) 2011-11-30 2016-08-23 Singapore Health Services Pte. Ltd. GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
SG11201407667UA (en) 2012-06-27 2015-02-27 Hoffmann La Roche MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD
RU2515475C1 (ru) 2012-11-15 2014-05-10 Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте
CA2943284A1 (en) 2014-03-21 2015-11-05 Igenomix S.L. Early detection of preeclampsia
BR112016029558A2 (pt) 2014-06-17 2017-08-22 Igenomix S L terapia de células-tronco em patologias endometriais

Also Published As

Publication number Publication date
LT3569697T (lt) 2022-04-25
ES2983444T3 (es) 2024-10-23
EP4012023C0 (en) 2024-05-15
SMT202400270T1 (it) 2024-07-09
DK3569697T3 (da) 2022-04-04
PL3158057T3 (pl) 2020-05-18
JP6920062B2 (ja) 2021-08-18
RU2017101147A (ru) 2018-07-17
PT3158057T (pt) 2019-07-19
PT3569697T (pt) 2022-05-02
WO2015193737A1 (en) 2015-12-23
JP2020138984A (ja) 2020-09-03
HRP20191240T1 (hr) 2019-11-01
LT3158057T (lt) 2019-09-25
EP4012023A1 (en) 2022-06-15
SMT201900400T1 (it) 2019-09-09
MX2016016756A (es) 2017-11-02
RU2725006C2 (ru) 2020-06-29
US20170128492A1 (en) 2017-05-11
MX377300B (es) 2025-03-07
RS59210B1 (sr) 2019-10-31
CN107073040A (zh) 2017-08-18
EP3569697B8 (en) 2022-04-27
EP3569697B1 (en) 2022-01-05
EP4012023B1 (en) 2024-05-15
CY1125938T1 (el) 2024-02-16
SMT202200155T1 (it) 2022-05-12
EP3158057A1 (en) 2017-04-26
RU2017101147A3 (enExample) 2019-02-06
EP3569697A1 (en) 2019-11-20
BR112016029558A2 (pt) 2017-08-22
CN116747241A (zh) 2023-09-15
ES2736117T3 (es) 2019-12-26
RS63093B1 (sr) 2022-04-29
SI3158057T1 (sl) 2019-10-30
EP3158057B1 (en) 2019-04-17
RS65719B1 (sr) 2024-08-30
AU2015275798B2 (en) 2021-03-25
ES2910306T3 (es) 2022-05-12
HUE058328T2 (hu) 2022-07-28
HRP20240798T1 (hr) 2024-09-27
HRP20220419T1 (hr) 2022-05-27
TR201910410T4 (tr) 2019-08-21
CY1122615T1 (el) 2021-03-12
CA2952559C (en) 2023-01-24
PL4012023T3 (pl) 2024-09-02
US11129851B2 (en) 2021-09-28
CA2952559A1 (en) 2015-12-23
JP2017522288A (ja) 2017-08-10
SI3569697T1 (sl) 2022-05-31
PL3569697T3 (pl) 2022-07-04
HUE067463T2 (hu) 2024-10-28
AU2015275798A1 (en) 2017-02-02
HUE044823T2 (hu) 2019-11-28

Similar Documents

Publication Publication Date Title
PL3492632T3 (pl) Sposoby traktowania materiałów zawierających lit
IL250689A0 (en) Resetting pluripotent stem cells
IL250511A0 (en) Crystalline forms of ibrutinib
HUE046262T2 (hu) Sejt
SG11201609265RA (en) Characterizing states of subject
SG11201708359TA (en) Generation of functional cells from stem cells
DK3171891T3 (da) Fremgangsmåde
PL3234071T3 (pl) Piec
PL3151327T3 (pl) Roztwór elektrolitu
IL254655A0 (en) Ibrutinib co-crystal
DK3157504T3 (da) Stamcellestimulerende sammensætninger
EP3037812C0 (en) ENZYME ELECTRODE
LT3237432T (lt) Baltymo gamyba
DK3132009T3 (da) Fremgangsmåde
DK3283210T3 (da) Fremgangsmåde
DK3569697T3 (da) Stamcelleterapi i endometriumpatologier
DK3374495T3 (da) Forbedrede fremgangsmåder til vævsfremstilling
SI3188599T1 (sl) Zdravljenje na osnovi anamorelina
SG11201610430QA (en) Growth-independent detection of cells
FR3024647B1 (fr) Transat de puericulture
FR3022129B1 (fr) Baignoire de puericulture
SG10201403640XA (en) Stem cells
FR3019594B1 (fr) Section additionnelle de poussee
FR3016113B1 (fr) Drague de coquillages
TWM489546U (en) Improved structure of comb